CSIMarket Company Name, Ticker, Competitors, else..
 
Eloxx Pharmaceuticals Inc   (NASDAQ: ELOX)
 
Price: $15.0300 $-0.97 -6.063%
Day's High: $16.239999771118164 Week Perf: -12.57 %
Day's Low: $ 14.04 30 Day Perf: -18.89 %
Volume (M): 27,603 52 Wk High: $ 23.40
Volume (M$): $ 0 52 Wk Avg: $5.01
Open: $15.95 52 Wk Low: $0.00



 Market Capitalization (Millions $) 66
 Shares Outstanding (Millions) 4
 Employees 10
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -4
 Cash Flow (TTM) (Millions $) 21
 Capital Exp. (TTM) (Millions $) 0

Business Description


Eloxx Pharmaceuticals Inc. is a biopharmaceutical company that specializes in the development and commercialization of novel therapeutics for genetic diseases. The company focuses on genetic diseases caused by nonsense mutations, which are mutations that prematurely stop the production of functional proteins. Eloxx develops small molecule drugs called ribosomal selective glycosides (RSGs) that can enable the ribosome to bypass the mutated part of the gene and continue protein synthesis, leading to the production of functional proteins. The company's lead product candidate, ELX-02, is being developed to treat cystic fibrosis and other diseases caused by nonsense mutations. Eloxx Pharmaceuticals aims to provide innovative treatment options for patients with genetic diseases where limited therapeutic options currently exist.


   Company Address: P.O. Box 274 Arlington 2476 MA
   Company Phone Number: 577-5300   Stock Exchange / Ticker: NASDAQ ELOX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BIIB        5.61% 
GILD        0.55% 
MGTX   -17.66%    
PLX        1.12% 
RGNX   -7.85%    
SGMO      0% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.49
Working Capital Ratio 1.99
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -34.72 $
Revenues (TTM) -
Cash Flow (TTM) 4.69 $
Cash 1.45 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -351,900
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.